AN2 Therapeutics, Inc.
ANTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001880438
In the last 90 days, AN2 Therapeutics, Inc. insiders filed 1 open-market purchase and 5 sales; 66 institutions reported holding it in 13F filings for Q2 2026, worth $119.0M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in AN2 Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +2 vs. Q4 2022
- Shares held
- 9.60M
- −162.4K (−1.7%) vs. Q4 2022
- Total value
- $94.8M
- +$1.82M (+2.0%) vs. Q4 2022
- New holders
- 3
- 20 more added
- Sold out
- 1
- 7 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 66 | $119.0M |
| Q1 2026 | 52 | $74.8M |
| Q4 2025 | 38 | $9.88M |
| Q3 2025 | 36 | $10.5M |
| Q2 2025 | 37 | $8.78M |
| Q1 2025 | 38 | $19.5M |
| Q4 2024 | 38 | $20.1M |
| Q3 2024 | 31 | $14.5M |
| Q2 2024 | 45 | $41.7M |
| Q1 2024 | 54 | $60.9M |
| Q4 2023 | 51 | $417.9M |
| Q3 2023 | 37 | $320.3M |
| Q2 2023 | 31 | $99.9M |
| Q1 2023 | 38 | $94.8M |
| Q4 2022 | 36 | $92.9M |
| Q3 2022 | 38 | $165.1M |
| Q2 2022 | 36 | $72.4M |
| Q1 2022 | 18 | $134.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding AN2 Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 3,773,517 | $37.2M | 0.84% | 00.0% | Unchanged |
| BVF Inc | 1,563,963 | $15.4M | 0.56% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,337,159 | $13.2M | 0.01% | +1760.0% | Added |
| Avidity Partners Management LP | 723,200 | $7.14M | 0.24% | −20,400−2.7% | Reduced |
| Vanguard Group Inc | 601,925 | $5.94M | 0.00% | +12,525+2.1% | Added |
| BlackRock Inc. | 483,429 | $4.77M | 0.00% | +38,220+8.6% | Added |
| Monashee Investment Management LLC | 247,467 | $2.44M | 0.67% | −202,533−45.0% | Reduced |
| Geode Capital Management, LLC | 144,947 | $1.43M | 0.00% | +21,862+17.8% | Added |
| Citigroup Inc | 134,473 | $1.33M | 0.00% | −75−0.1% | Reduced |
| State Street Corp | 96,884 | $956.2K | 0.00% | +5,862+6.4% | Added |
| Northern Trust Corp | 76,134 | $751.4K | 0.00% | −4,684−5.8% | Reduced |
| Bridgeway Capital Management, LLC | 52,500 | $518.2K | 0.01% | +52,500 | New |
| UBS Group AG | 52,225 | $515.5K | 0.00% | +770+1.5% | Added |
| Alyeska Investment Group, L.P. | 48,426 | $478.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 45,532 | $449.4K | 0.00% | +4,227+10.2% | Added |
| Barclays PLC | 32,773 | $323.5K | 0.00% | +2,715+9.0% | Added |
| Bank of New York Mellon Corp | 31,684 | $312.7K | 0.00% | +824+2.7% | Added |
| Charles Schwab Investment Management Inc | 29,898 | $295.1K | 0.00% | +5,000+20.1% | Added |
| Bank of America Corp | 25,916 | $255.8K | 0.00% | +1,202+4.9% | Added |
| Private Advisor Group, LLC | 22,008 | $217.2K | 0.00% | +11,000+99.9% | Added |
| Nuveen Asset Management, LLC | 15,546 | $153.0K | 0.00% | +481+3.2% | Added |
| Rhumbline Advisers | 11,710 | $116.0K | 0.00% | +1,628+16.1% | Added |
| JPMorgan Chase & Co | 8,511 | $84.0K | 0.00% | +2,247+35.9% | Added |
| Deutsche Bank AG | 6,815 | $67.3K | 0.00% | +2,026+42.3% | Added |
| ETF Managers Group, LLC | 6,742 | $66.5K | 0.00% | +6,742 | New |
| New York State Common Retirement Fund | 5,879 | $58.0K | 0.00% | +54+0.9% | Added |
| American International Group, Inc. | 5,362 | $52.9K | 0.00% | +107+2.0% | Added |
| California State Teachers Retirement System | 4,131 | $40.8K | 0.00% | −305−6.9% | Reduced |
| Tower Research Capital LLC (TRC) | 2,797 | $28.0K | 0.00% | +1,941+226.8% | Added |
| STRS Ohio | 2,300 | $22.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,966 | $19.4K | 0.00% | +1,966 | New |
| Amalgamated Bank | 1,767 | $17.0K | 0.00% | −85−4.6% | Reduced |
| Legal & General Group Plc | 1,166 | $11.6K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 642 | $6.00K | 0.00% | −1,109−63.3% | Reduced |
| Ameritas Investment Partners, Inc. | 348 | $3.44K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 307 | $3.03K | 0.00% | +56+22.3% | Added |
| Advisor Group Holdings, Inc. | 200 | $1.97K | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Woodline Partners LP | 0 | $0 | 0.00% | −107,300−100.0% | Sold out |